Literature DB >> 2289295

Surveillance and control of meningococcal meningitis epidemics in refugee populations.

P S Moore1, M J Toole, P Nieburg, R J Waldman, C V Broome.   

Abstract

Epidemics of communicable diseases pose a direct threat to refugee and internally displaced populations, and could lead to high mortality rates and a disruption of basic health care services. Several large refugee populations live in regions of high meningococcal disease endemicity and their camps are at risk for outbreaks of meningococcal meningitis. Surveillance in these camps allows early detection and control of impending outbreaks. Confirmation of meningococcal disease can be performed under field conditions using simple techniques, such as latex agglutination. Isolates should be obtained for serogroup confirmation and antibiotic sensitivity studies at reference laboratories. Serogroup information is used to determine the risk of widespread epidemic disease and the utility of available vaccines. During epidemics, treatment regimens should be standardized, preferably with an effective single-dose antibiotic. Mass vaccination campaigns should be initiated, the populations at high risk being targeted for vaccination as quickly as possible. When the risk of epidemic disease is deemed to be high, preemptive vaccination may be warranted. Daily surveillance using a simple case definition is essential during an epidemic to determine the effectiveness of control measures and to delineate high-risk groups for vaccination or chemoprophylaxis. Many of these recommendations can be applied also to other populations in developing countries.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2289295      PMCID: PMC2393193     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

Review 1.  Global epidemiology of meningococcal disease.

Authors:  B Schwartz; P S Moore; C V Broome
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

2.  Intercontinental spread of an epidemic group A Neisseria meningitidis strain.

Authors:  P S Moore; M W Reeves; B Schwartz; B G Gellin; C V Broome
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

3.  Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa.

Authors:  B A Crowe; R A Wall; B Kusecek; B Neumann; T Olyhoek; H Abdillahi; M Hassan-King; B M Greenwood; J T Poolman; M Achtman
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

4.  An analysis of mortality trends among refugee populations in Somalia, Sudan, and Thailand.

Authors:  M J Toole; R J Waldman
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

5.  Meningococcal disease and season in sub-Saharan Africa.

Authors:  B M Greenwood; A K Bradley; R A Wall
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

Review 6.  Public health considerations in the management of meningococcal disease.

Authors:  J B McCormick; J V Bennett
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

Review 7.  Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983.

Authors:  T Olyhoek; B A Crowe; M Achtman
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

8.  Shift in the age-distribution of meningococcal disease as predictor of an epidemic?

Authors:  H Peltola; J M Kataja; P H Mäkelä
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

9.  Group A meningococcal carriage in travelers returning from Saudi Arabia.

Authors:  P S Moore; L H Harrison; E E Telzak; G W Ajello; C V Broome
Journal:  JAMA       Date:  1988-11-11       Impact factor: 56.272

10.  Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys.

Authors:  I S Blakebrough; B M Greenwood; H C Whittle; A K Bradley; H M Gilles
Journal:  Ann Trop Med Parasitol       Date:  1983-04
View more
  7 in total

1.  Reply to "A refugee patient with meningococcal meningitis type B."

Authors:  Alexandra Dretler; Nadine Rouphael; David Stephens
Journal:  Hum Vaccin Immunother       Date:  2018-07-09       Impact factor: 3.452

2.  Surveillance for the Expanded Programme on Immunization.

Authors:  F T Cutts; R J Waldman; H M Zoffman
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

3.  Blood stained cerebrospinal fluid responsible for false positive reactions of latex particle agglutination tests.

Authors:  P A Camargos; M S Almeida; G L Filho; K W Batista; A G Carvalho; C L Pereira
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

4.  Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic.

Authors:  P Kriz; J Vlckova; M Bobak
Journal:  Epidemiol Infect       Date:  1995-12       Impact factor: 2.451

5.  Defining and detecting malaria epidemics in the highlands of western Kenya.

Authors:  Simon I Hay; Milka Simba; Millie Busolo; Abdisalan M Noor; Helen L Guyatt; Sam A Ochola; Robert W Snow
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

Review 6.  Maintaining efficient logistics and supply chain management operations during and after coronavirus (COVID-19) pandemic: learning from the past experiences.

Authors:  Ubaid Illahi; Mohammad Shafi Mir
Journal:  Environ Dev Sustain       Date:  2021-01-19       Impact factor: 3.219

7.  Meningococcal infections among refugees and immigrants: silent threats of past, present and future.

Authors:  Ener Cagri Dinleyici; Ray Borrow
Journal:  Hum Vaccin Immunother       Date:  2020-04-29       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.